CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Aravind Eye Care System and Alcon have launched a new [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Telix has dosed the first patient in a Phase 3 [...]

Samsung Biologics has announced plans to acquire peptide CDMO PolyPeptide [...]

A study published in The New England Journal of Medicine [...]

Latent Labs has launched its artificial intelligence-powered drug design platform [...]

A two-minute digital cognitive assessment developed by Cumulus Neuroscience performed [...]